I see that Briefing.com posted another ad for their new ‘Briefing Special Situations Trader’ product today:

13:01 Briefing Trader

Yesterday, on Briefing Trader we highlighted a couple of very speculative names we thought could see gains short-term. One, Catuity (CTTY 16.47 +4.57, +38%), has ralied 57% since our profile. Another, MM Companies (OTC: MMCO.OB 3.24 +0.92, +40%), has rallied as much as 113% since our profile yesterday… Other calls of interest on Briefing Trader included a call to get Long Momenta Pharma (MNTA 27.85 +2.29) yesterday at $24.10. As well as Trading Alerts on Rediff.com India (REDF) at $10.63, Dril-Quip (DRQ) at $36.62, China Medical Tech (CMED) at $18.00 and a call to Short Oil stocks into yesterday’s Inventory Data…. Briefing Trader is a product that makes specific trading calls on individual stocks (from both a technical and fundamental perspective). Note that this product is targeted at the most aggressive of traders and is not appropriate for most.

I’d like to hear from somebody who’s actually using it. Briefing loves to highlight the calls that work out well but what about the duds? Let me know what you think about it. (I see that a couple of people don’t think it’s worth the $300/month)